Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21444871

Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2011 May 1
First author
Dueñas-González A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2011 May 1;29(13):1654-6. doi: 10.1200/JCO.2010.34.1966.
    note
    Source null
    related pmid
    21444860
    relationship
    Comment in

Authors and identifiers

  1. name
    Dueñas-González A
    type
    Author
  2. name
    Zarbá JJ
    type
    Author
  3. name
    Patel F
    type
    Author
  4. name
    Alcedo JC
    type
    Author
  5. name
    Beslija S
    type
    Author
  6. name
    Casanova L
    type
    Author
  7. name
    Pattaranutaporn P
    type
    Author
  8. name
    Hameed S
    type
    Author
  9. name
    Blair JM
    type
    Author
  10. name
    Barraclough H
    type
    Author
  11. name
    Orlando M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Dueñas-González A
    type
    Author
  2. name
    Zarbá JJ
    type
    Author
  3. name
    Patel F
    type
    Author
  4. name
    Alcedo JC
    type
    Author
  5. name
    Beslija S
    type
    Author
  6. name
    Casanova L
    type
    Author
  7. name
    Pattaranutaporn P
    type
    Author
  8. name
    Hameed S
    type
    Author
  9. name
    Blair JM
    type
    Author
  10. name
    Barraclough H
    type
    Author
  11. name
    Orlando M
    type
    Author
bibliography ids
  1. nci-bib-5841f731cc6c54ae8ca15986
book metadata
content sha256
c07239ec8725a22a4ef25417616c01dd561306d7dc0b0ffb8946f2e7a09edce6
document type
citation
dois
  1. 10.1200/JCO.2009.25.9663
electronic publication date
display
2011 Mar 28
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21444871
immutable id
pubmed:21444871@c07239ec8725a22a4ef25417616c01dd561306d7dc0b0ffb8946f2e7a09edce6
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
13
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1678-85
volume
29
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2011 May 1;29(13):1654-6. doi: 10.1200/JCO.2010.34.1966.
    note
    Source null
    related pmid
    21444860
    relationship
    Comment in
outcomes validated
false
pmid
21444871
provenance
batch id
a366a1bc8ed89d8d7ca5
provider
NCBI PubMed ESummary
record sha256
3fff33519018a5a6a901e2cce50bc6efdafc41f5c60b8b0c8fc573524cf4ef64
response sha256
c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
retrieved at
2026-09-09T23:46:40.540025+00:00
publication date
display
2011 May 1
precision
day
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21444871/
title
Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.

Preserved source evidence · Not medical advice